Advice
in the absence of a submission from the holder of the marketing authorisation
telavancin hydrochloride (Vibativ®) is not recommended for use within NHS Scotland.
Indication under review: treatment of adults with nosocomial pneumonia (NP) including ventilator associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus aureus (MRSA).
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice110KB (PDF)
Medicine details
- Medicine name:
- telavancin hydrochloride (Vibativ)
- SMC ID:
- 1015/14
- Indication:
- Treatment of adults with nosocomial pneumonia (NP) including ventilator associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus aureus (MRSA).
- Pharmaceutical company
- Clinigen Healthcare Ltd
- BNF chapter
- Infections
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 10 November 2014